Qiagen NV (WBO:QGE2)
€ 40.8 -0.54 (-1.31%) Market Cap: 9.01 Bil Enterprise Value: 9.48 Bil PE Ratio: 137.61 PB Ratio: 2.86 GF Score: 87/100

Qiagen NV Analyst and Investor Day 2019 Transcript

Jun 20, 2019 / 05:00PM GMT
Release Date Price: €37.53 (+1.05%)
John Gilardi
QIAGEN N.V. - VP of Corporate Communications & IR

Thank you very much, everyone. Really appreciate that you could make it today -- all of you who could make it here today in person and especially to those of you who have traveled more than a few blocks to come here. Especially, those of you who have come overseas. The last time we did an investor even together was in November 2006. So now we are going to fast forward 2-1/2 years and we are going to talk today to you about QIAGEN and how we are emerging as a stronger, focused, and differentiated leader in molecular testing. Before we begin and I handover to Peer, let me cover our safe harbor statements. The discussions and responses to your questions today will reflect management's views as of today, Thursday, June 20, 2019. We will be making statements and provide any responses to your questions that state our intentions, beliefs, expectations, and predictions of the future. These constitute forward-looking statements for the purpose of the safe harbor provisions. These statements involve risk and uncertainties that could cause actual

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot